Finance

Lists
Why is NSRX up 2.69%?
Dive Deeper
NSRX:NYSEAMERICAN
Nasus Pharma Ltd
$3.44
+2.69%
(+0.090) 1D
$3.47
+0.81% (+0.028)
After hours
Closed: Sep 21, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NSRX...
Open
$3.46
High
$3.53
Low
$3.35
Mkt. cap
40.29M
Avg. vol.
12.02K
Volume
6.43K
52-wk high
$9.50
52-wk low
$1.98
EPS
-$1.13
Shares outstanding
11.71M
No. of employees
7
Open
$3.46
High
$3.53
Low
$3.35
Mkt. cap
40.29M
Avg. vol.
12.02K
Volume
6.43K
52-wk high
$9.50
52-wk low
$1.98
EPS
-$1.13
Shares outstanding
11.71M
No. of employees
7
News stories
From web sources and news partners
About Nasus Pharma Ltd
CEO-
Employees7
Founded2019
Headquarters-
SectorPharmaceutical industry
Websitenasuspharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
1.29M
1.29M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
1.73M
1.73M
Operating expense
-
-
3.02M
3.02M
Total operating expenses
-
-
3.02M
3.02M
Operating income
-
-
-3.02M
-3.02M
Other non operating income
-
-
-17.50K
-17.50K
EBT including unusual items
-
-
-2.97M
-2.97M
EBT excluding unusual items
-
-
-2.97M
-2.97M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-2.97M
-2.97M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
64.00K
64.00K
Interest expense
-
-
-
-
Net interest expenses
-
-
64.00K
64.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps